Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
12.00
-0.03 (-0.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vicarious Surgical stock have an average target of 10.25, with a low estimate of 10 and a high estimate of 10.5. The average target predicts a decrease of -14.58% from the current stock price of 12.00.
Analyst Consensus: Hold
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for RBOT stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | -12.50% | Nov 13, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $12 | Hold | Maintains | $30 → $12 | n/a | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | -16.67% | Jul 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $45 → $30 | Hold | Maintains | $45 → $30 | +150.00% | Mar 5, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $18 | Hold | Initiates | $18 | +50.00% | Dec 4, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-11.29
from -14.70
EPS Next Year
-10.34
from -11.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -11.26 | -7.43 | -5.15 | |
| Avg | -11.29 | -10.34 | -8.21 | |
| Low | -11.13 | -11.74 | -11.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.